key: cord-0724452-dvtwe3r9 authors: Nidom, Reviany V.; Indrasari, Setyarina; Normalina, Irine; Nidom, Astria N.; Afifah, Balqis; Dewi, Lestari; Putra, Andra Kusuma; Ansori, Arif N. M.; Kusala, Muhammad K. J.; Alamudi, Mohammad Y.; Nidom, Chairul A. title: An Updated Investigation Prior To COVID-19 Vaccination Program In Indonesia: Full-Length Genome Mutation Analysis Of SARS-CoV-2 date: 2021-01-27 journal: bioRxiv DOI: 10.1101/2021.01.26.426655 sha: 4077a3d2927e5335ff848f41714eca4d636808b4 doc_id: 724452 cord_uid: dvtwe3r9 Introduction Indonesia kick-started the big project of COVID-19 vaccination program in January 2021 by employed vaccine to the president of Indonesia. The outbreak and rapid transmission of COVID-19 have endangered the global health and economy. This study aimed to investigate the full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates as 12 January 2021. Methods All data of isolates was extracted from the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database. CoVsurver was employed to investigate the full-length genome mutation analysis of all isolates. Furthermore, this study also focused on the unlocking of mutation in Indonesian SARS-CoV-2 isolates S protein. WIV04 isolate that was originated from Wuhan, China was used as a virus reference according to CoVsurver default. All data was visualized using GraphPad Prism software, PyMOL, and BioRender. Results This study result showed that a full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates was successfully discovered. Every single mutation in S protein was described and then visualised by employing BioRender. Furthermore, it also found that D614G mutation appeared in 103 Indonesian SARS-CoV-2 isolates. Conclusion To sum up, this study helps to observe the spread of the COVID-19 transmission. However, it would like to propose that the epidemiological surveillance and genomics studies might be improved on COVID-19 pandemic in Indonesia. SARS-CoV-2 firstly occurred in China and then transmitted sporadically worldwide. In March 2020, WHO announced that the infection was a pandemic. COVID-19 outbreak and rapid transmission have endangered global health and economy 1 . This crisis has called for an extensive scientific mobilization of studies on SARS-CoV-2 focusing its clinical aspects, characteristics, and its mechanism of transmission, with the ultimate aim of counteracting the devastating outcomes 2, 3 . Recently, there have been around 92 million people globally who have been infected by the seventh coronavirus and more than 2 million deaths as the fast result of this pandemic. Specifically, there are more than 850,000 cases and around 25,000 people died in Indonesia. These data are derived from Johns Hopkins University online website that tracks COVID-19 cases in real-time 4 . Meanwhile, on coronaviruses themselves, the family Coronaviridae is categorised into four different genera: Gammacoronavirus, Deltacoronavirus, Betacoronavirus, and Alphacoronavirus. Both animals and humans can be infected by coronaviruses 5 . Moreover, SARS-CoV-2 genome is a single-stranded positive-sense RNA of roughly 30,000 nucleotides. There are four structural proteins encoded by the genome and spike (S) protein is the most important one 6 . It is because S protein is the primary target antigen in the SARS-CoV-2 vaccine 7 . Previously, the candidate for a peptide-based vaccine against the virus based on the four structural proteins was identified 8, 9 . In addition, the interaction between the host and the virus that causes infection involves a complex response of immune system 10, 11 . On the other hand, we demonstrated the paradoxical phenomenon called antibody-dependent enhancement (ADE) within the Indonesian isolates 12 . Therefore, ADE has become a tipping point in the cultivation of antibody-based therapies and vaccines 10, 11 . Recently, scientists are attempting to generate vaccines to fight against SARS-CoV-2 worldwide, with protein-based vaccines as the most advanced types and the private sector is at the forefront of this study 13, 14, 15, 16 . Unexpectedly/uncontrollably, the mutation rate of Coronaviridae is reminding high. Various studies reported the mutation might be implicated the efficacy of vaccines or other therapeutic strategies 17, 18, 19 . Furthermore, the newest type of SARS-CoV-2 lineage occurred in UK at the end of 2020 and this case predicted as sporadically would increase the number of the COVID-19 patients in UK. Thus, investigating the full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates became the goal of this study. The data extraction of all Indonesian isolates (166 isolates) with SARS-CoV-2 from the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database was completed on 12 January 2021. This study only used the complete genome and high coverage criteria according to the GISAID EpiCoV standard. All of 166 Indonesian SARS-CoV-2 isolates were derived from various provinces in Indonesia, for example: Special Region of Aceh, North Sumatra, Lampung, Banten, Special Capital Region of Jakarta, West Java, Central Java, Special Region of Yogyakarta, East Java, and so on. This study identified the total isolates in every province, GISAID clades, and lineages. All data were visualized using GraphPad Prism software. Furthermore, WIV04 isolate (GISAID clade: L; lineage: B) collected from a female retailer at Huanan Seafood Wholesale Market and submitted by the Wuhan Institute of Virology, Chinese Academy of Sciences, China was applied as a virus reference based on CoVsurver default. Every single gene of 166 Indonesian SARS-CoV-2 isolates was investigated, such as NSP1-16, S, NS3, E, M, NS6, NS7a, NS7b, NS8, and N. Also, D614G mutation and S protein mutations in all isolates were identified. We employed CoVsurver to investigate the full-length genome mutation analysis of all isolates. All data were visualized using GraphPad Prism software and BioRender. 3D Structure Visualization Meanwhile, S protein mediates the entry and the new virus membrane fusion and is the main target for many studies of antiviral drugs and vaccines 28, 29 . S1 and S2 are the two domains of the virus S protein (Figure 2 ). S1 is conscientious for binding to host cellular receptors. Besides the efficacy of several therapies which include disrupting protease inhibitors, small RNAs, neutralizing antibodies, fusion blockers, S protein inhibitors, ACE2 blockers, however, the in vitro studies on S protein inhibitors have been unsatisfactory 30 . Many methods have been employed to produce vaccines using S protein as an antigen 8, 31 . Thus, it is very important to investigate the S protein from Indonesian SARS-CoV-2 isolates. Scientists have demonstrated that mutations occur in the virus genome globally 7, 9, 32, 33 37 . Simultaneously, this study reported various S protein mutations such as A222, S477, D614, Q677, and so on. Further research was highly considered that S protein mutations to affect vaccination program worldwide 38, 39, 40 . Recent publications shows that one of the most notable amino acid mutations is D614G 12, 13 . Based on these recent studies, the virus virulence and the increase of viral loads in COVID-19 patients characterise the occurrence of D614G mutation 40, 41 . While, based on the current available information, the infectivity as well as the receptor binding, fusion activation, or ADE enhancement can be influenced by D614G mutation in several ways 10, 11, 12 . An antibody escape is considered as another mutation mechanism like the upcoming form of D614G which can be accelerated by an antigenic drift. If the sensitivity of neutralizing antibody can be affected by D614G mutation in SARS-CoV-2 or vice versa, then, the ADE activity also can be monitored in the SARS-CoV study, thus, D614G can be considered as an intermediate antibody escape which puts people to be more vulnerable for second infections 12, 40, 42 . In this study, D614G mutation was detected in 103 Indonesian SARS-CoV-2 isolates. All the isolates were mostly from the West Java, East Java, Special Region of Yogyakarta, Special Capital Region of Jakarta, and Central Java, respectively (Figure 2 ). This result is in line with a study by Zhang et al. on D614G mutation which discovered that S1 residue 614 is in a close proximity to S2 domain. An altered release or shedding of S1 domain after cleavage at S1/S2 junction might be displayed by the ratio between S1 and S2 domains in the virion. Glycine Amino Acid found at residue 614 of S protein G614 secures the interaction between S1 and S2 domains and limits S1 shedding. D614G mutation has been previously speculated in raising an open configuration of S protein that is more advantageous to ACE2 association 40 . Therefore, SARS-CoV-2 S protein D614G mutation is highly believed in promoting the virion spike density and infectivity and it is also highly speculated that this mutation might be influence further mutations. In addition, the previous study also reported that the type of mutation emerged in the virus isolates were originated from canine, environment, Felis catus, Mus musculus, Mustela lutreola, and Panthera tigris jacksoni 12 . In the meantime, compared to most other microorganisms, the rates of RNA viruses' mutations are much higher 43 . An elevated mutation rate can lead to an increase in virulence and a high potential for adaptive evolution 43, 44 . This capability boosts the chance of zoonotic viral pathogens to establish human-to-human transmission and permits them to enhance their virulence 45 . This study provides the fundamental data for accomplished studies into the medication and prevention of COVID-19. Indonesian SARS-CoV-2 genomic data extraction would be valuable in vaccine construction and options in medication. In fact, mining the data of the Indonesian SARS-CoV-2 variants and molecular epidemiology could enable the mapping of its origin and the tracking of its transmission 46 . In line with this, the sequence investigation performs an important role in viral surveillance, public health policy problems, and host identification 46, 47 . Thus, high-speed detection of mutations from the Indonesian SARS-CoV-2 is mandatory in the unlocking to the COVID-19 pandemic in Indonesia. Currently, the availability of COVID-19 vaccine is limited, not many people can access it. In countries that have not implemented large-scale active case testing and isolation, controlling the spread of the virus can be a challenge. In this case, transmission suppression relies primarily on the community adherence to non-pharmacological strategies such as social distancing, the mandatory mask using, and hand washing 48, 49, 50, 51 . Inevitably, as the result of SARS-CoV-2 outbreaks, many countries declared medical emergency which led to economic emergency since those countries enforcing limited or strict mobility both regionally and nationally 52, 53, 54 . Thus, in regulating and containing further transmission of COVID-19, it is a fundamental move to discover the characteristics of SARS-CoV-2 genome and constitute the systems for observing SARS-CoV-2 during this pandemic. Furthermore, the recognition of genotypes related to temporal infectious clusters and specific geographic areas recommends that the employment of genomic data is highly recommended in observing and tracking the further spreading of SARS-CoV-2. Likewise, researchers might be able to introduce the origin of a specific variant and observe the virus transmission by acknowledging the specific SARS-CoV-2 variants and connecting them using a molecular epidemiology approach. Ergo, it can be argued that this study might become an important tool in regulating the COVID-19 pandemic in Indonesia. In conclusion, this study successfully identified the full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates. This study helps in observing the spread of the COVID-19 transmission. However, we proposed that the epidemiological surveillance and genomics studies might be improved on COVID-19 pandemic in Indonesia. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java Emergence of SARS-CoV-2 through recombination and strong purifying selection Clinical features of patients infected with 2019 novel coronavirus in Wuhan An interactive web-based dashboard to track COVID-19 in real time Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses Genetic diversity and evolution of SARS-CoV-2 Characterization of the spike glycoprotein and construction of an epitope-based vaccine candidate against Indonesian SARS-CoV-2: In silico study Immunoinformatic investigation of three structural protein genes in Indonesian SARS-CoV-2 isolates The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development Dengue fever, COVID-19 (SARS-CoV-2), and antibodydependent enhancement (ADE): A perspective Investigation of the D614G mutation and antibody-dependent enhancement sequences in Indonesian SARS-CoV-2 isolates and comparison to Southeast Asian isolates Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review The race for coronavirus vaccines: A graphical guide A review on promising vaccine development progress for COVID-19 disease Next-generation vaccine platforms for COVID-19 Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Recognition of aerosol transmission of infectious agents: A commentary Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution. bioRxiv The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between spike-ACE2 caused by the viral N501Y mutation Transmission of SARS-CoV-2 lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv Genomic evidence of a SARS-CoV-2 reinfection case with E484K spike mutation in Brazil The proximal origin of SARS-CoV-2 A Review of SARS-CoV-2 and the ongoing clinical trials Treatment options for COVID-19: The reality and challenges Vaccines against coronavirus disease: Target proteins, immune responses, and status of ongoing clinical trials Genotyping coronavirus SARS-CoV-2: Methods and implications Site-specific glycan analysis of the SARS-CoV-2 spike Evolutionary analysis of SARS-CoV-2: How mutation of non-structural protein 6 (NSP6) could affect viral autophagy Genetic variant severe acute respiratory syndrome coronavirus 2 isolates in Thailand Full-genome sequences of the first two SARS-CoV-2 viruses from India Full genome sequence of the first SARS-CoV-2 detected in Mexico Genomic characterization of a novel SARS-CoV-2 Genome-wide identification and characterization of point mutations in the SARS-CoV-2 genome Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera Threats from new variants SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus ADE and hyperinflammation in SARS-CoV2 infection-comparison with dengue hemorrhagic fever and feline infectious peritonitis Potential of live pathogen vaccines for defeating the COVID-19 pandemic: History and mechanism Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight The establishment of reference sequence for SARS-CoV-2 and variation analysis The identification of first COVID-19 cluster in Indonesia The establishment of reference sequence for SARS-CoV-2 and variation analysis Scientific and ethical basis for social-distancing interventions against COVID-19 COVID-19 and social distancing COVID-19: Towards controlling of a pandemic COVID-19: Prevention and control measures in community COVID-19, a worldwide public health emergency The global impact of the coronavirus pandemic Coronavirus disease 2019 (COVID-19) pandemic and economic impact This study was fully supported by the Professor Nidom Foundation, Indonesia (Grant Number: 005/PNF-RF/07/2020). We would like to take this opportunity to express our deepest condolences to the victims of COVID-19. We would also like to pay tribute to our frontline heroes who have fought continuously to this day. Thankfully, we also recognize the authors from the originating and submitting laboratories of GISAID database on which the samples were derived from. We would like to thank to National Institute of Health Research and Development, Ministry of Health, Indonesia (Balitbangkes Kemenkes) for the supports. Additionally, we also thank Dewi Sartika, M.Ed. for her help in editing the manuscript.